Dihydrostreptomycin sulfate is a semi-synthetic broad-spectrum aminoglycoside antibiotic produced commonly by the reduction of streptomycin. It is used primarily in the treatment of tuberculosis.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Synonyms: Dihydrostreptomycin sesquisulfate
Molecular Formula: C21H41N7O12·1.5H2SO4
Molecular Weight: 730.71
Linear Structural Formula: C21H41N7O12 · 3/2H2SO4
MDL Number: MFCD00070252
Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.